The In Vitro Cytotoxic Effect of Elesclomol on Breast Adenocarcinoma Cells Is Enhanced by Concurrent Treatment with Glycolytic Inhibitors.

Elesclomol 对乳腺腺癌细胞的体外细胞毒性作用可通过与糖酵解抑制剂同时治疗而增强